Literature DB >> 2989014

Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.

M Haftek, S Jabłonska, G Orth.   

Abstract

The characterization of different types of human papilloma viruses made it possible to study the specific immune responses to purified viral antigens in patients with warts. The specific cell-mediated immunity was investigated by means of a leukocyte migration inhibition factor test in 9 patients with epidermodysplasia verruciformis and 4 patients with regressing plane warts. The results show a significant increase in specific cell-mediated reactivity concomitant with the regression of the warts.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2989014     DOI： 10.1159/000249535

Source DB:  PubMed          Journal:  Dermatologica        ISSN： 0011-9075


  4 in total

Review 1.  HPV Vaccines: today and in the Future.

Authors:  Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

Review 2.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

3.  Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.

Authors:  P C van Voorst Vader; M C de Jong; R Blanken; C G Kallenberg; A Vermey; J M Scheres
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation.

Authors:  Maciej Lazarczyk; Cécile Dalard; Myriam Hayder; Loïc Dupre; Béatrice Pignolet; Slawomir Majewski; Francoise Vuillier; Michel Favre; Roland S Liblau
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.